Literature DB >> 13489320

Antithyroid activity of N-phthalyl glutamic acid imide (K17).

J M MURDOCH, G D CAMPBELL.   

Abstract

Entities:  

Keywords:  HYPNOTICS AND SEDATIVES/effects; THYROID ANTAGONISTS

Mesh：

Substances：

Year:  1958        PMID： 13489320      PMCID： PMC2027087          DOI： 10.1136/bmj.1.5062.84

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  [N-phthalyl-glutamic acid imide; experimental studies on a new synthetic product with sedative properties].

Authors:  H KELLER; W KUNZ; H MUCKTER
Journal:  Arzneimittelforschung       Date:  1956-08

2.  [Clinical studies with the sedative K 17 in tuberculosis sanatoria and general practice].

Authors:  G STARK
Journal:  Praxis       Date:  1956-10-18

3.  [Clinical studies with a new sedative and hypnotic].

Authors:  H ESSER; F HEINZLER
Journal:  Ther Ggw       Date:  1956-10
  3 in total
  7 in total

1.  Neuropathy after intake of thalidomide (distaval).

Authors:  P M FULLERTON; M KREMER
Journal:  Br Med J       Date:  1961-09-30

2.  The interpretation of the serum protein-bound iodine: A review.

Authors:  J D Acland
Journal:  J Clin Pathol       Date:  1971-04       Impact factor: 3.411

Review 3.  Thyroid dysfunction from antineoplastic agents.

Authors:  Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

4.  Increased serum tumor necrosis factor α levels in patients with lenalidomide-induced hypothyroidism.

Authors:  Wade T Iams; Megan L Hames; Judy P Tsai; Kimberly B Dahlman; Mahsa S Talbott; Kristy L Richards; Nishitha M Reddy
Journal:  Exp Hematol       Date:  2014-10-28       Impact factor: 3.084

Review 5.  Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.

Authors:  V Günzler
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

6.  Pharmacological properties of thalidomide (alpha-phthalimido glutarimide), a new sedative hypnotic drug.

Authors:  G F SOMERS
Journal:  Br J Pharmacol Chemother       Date:  1960-03

7.  Pomalidomide-induced hypothyroidism.

Authors:  Sulaiman Haji Ali; K Aljenaee; W A Wan Mahmood; M Hatunic
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-12-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.